SPHS Insider Trading Activity and SEC Form 4 Filings
SPHS insider trading summary
No open-market insider purchases or sales of Sophiris Bio Inc. (SPHS) have been reported on SEC Form 4 in the past 12 months.
Latest SPHS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 19, 2018 | Randall E Woods | President & Chief Exec Officer | Buy | $26K (10,000 @ $2.63) |
| Dec 18, 2014 | Lars Ekman | Director | Sell | $5K (9,663 @ $0.47) |
| Dec 15, 2014 | MVA Investors, LLC | 10% Owner | Sell | $52K (84,707 @ $0.61) |
| Dec 15, 2014 | Boxer Asset Management Inc. | 10% Owner | Sell | $52K (84,707 @ $0.61) |
| Dec 15, 2014 | MVA Investors, LLC | 10% Owner | Sell | $486K (796,772 @ $0.61) |
| Dec 15, 2014 | Boxer Capital, LLC | 10% Owner | Sell | $52K (84,707 @ $0.61) |
| Dec 15, 2014 | Joseph Lewis | 10% Owner | Sell | $52K (84,707 @ $0.61) |
| Dec 15, 2014 | Boxer Asset Management Inc. | 10% Owner | Sell | $486K (796,772 @ $0.61) |
| Dec 15, 2014 | Boxer Capital, LLC | 10% Owner | Sell | $486K (796,772 @ $0.61) |
| Dec 15, 2014 | Joseph Lewis | 10% Owner | Sell | $486K (796,772 @ $0.61) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.